Ionis Pharmaceuticals Shares Fall After Pelacarsen Phase 3 Trial Misses Primary Endpoint
Ionis Pharmaceuticals (NASDAQ:IONS) shares fell 13. 1% to $50.
Tuesday, September 8, 2026
Search covers the most recently published. For the full archive, browsethe topics.
5 results for"Sexual Harm Prevention Order"
Ionis Pharmaceuticals (NASDAQ:IONS) shares fell 13. 1% to $50.
Sigma Lithium (NASDAQ:SGML) shares fell nearly 12. 0% in premarket trading after a Brazilian federal court ordered the suspension of environmental permits an...
Cricket News: India continue to make their presence felt at the top of the Women’s T20I bowling rankings, with Sree Charani holding on to the No. 1 spot and Deepti .
Biohaven Pharmaceutical (NYSE:BHVN) shares fell 1. 9% to $15.
El corredor del Kern Pharma atraviesa LaVuelta a buen nivel, confía en que el equipo pueda encontrar la victoria que persigue y admite en MARCA que, a día de hoy, no seguirá en 2027